Viral reactivation with natalizumab


The clinical use of the alpha-4 integrin antagonist natalizumab may be associated with reactivation of other viruses, according to a study conducted in Ireland (Lonergan et al. J Neurovirol 2009; epublished August 9, 2009).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page